|
|
||||||||
Departments of 2 Medicine and 1 Cellular and Molecular Medicine, University of Ottawa and Ottawa General Hospital, Ottawa, Ontario, Canada K1H 8L6
| |
ABSTRACT |
|---|
|
|
|---|
Nitric oxide (NO)
derived from neuronal NO synthase (nNOS) in the kidney inner medulla
has been implicated in the regulation of arterial blood pressure. The
purpose of the present study was to determine the effect of high
dietary NaCl on the expression of nNOS in the rat inner medullary
collecting duct (IMCD). After 3 days or 3 wk of high (4.0%)-NaCl diet
in rats, urinary
NO
2/NO
3 excretion significantly increased. In freshly microdissected IMCD, nNOS
was readily detected by immunofluorescence with polyclonal antibody, an
effect that was completely blocked by neutralization of antibody with
immunizing antigen. In rats fed a 4.0% NaCl diet for 3 days, IMCD nNOS
mRNA, detected by RT-PCR, did not change from control values (0.3%
NaCl, 19.84 ± 1.57 × 103, vs. 4.0% NaCl, 20.44 ± 3.14 × 103 cpm;
P = not significant,
n = 3). By Western blotting however, nNOS protein expression significantly increased (0.3% NaCl, 0.51 ± 0.12, vs. 4.0% NaCl, 0.92 ± 0.14 arbitrary units;
P < 0.05, n = 5). After 3 wk of 4.0% dietary
NaCl, expression of nNOS mRNA and protein in IMCD did not differ
significantly from control values. In contrast to these data, renal
cortical expression of nNOS mRNA and protein was significantly
decreased after 4.0% NaCl diet for 3 days. High dietary NaCl had no
significant effect on expression of mRNA for inducible NO synthase
(iNOS) in IMCD after either 3 days or 3 wk. In summary, our data
indicate that nNOS mRNA and protein are expressed in IMCD and that high
dietary NaCl differentially regulates nNOS expression in IMCD and
cortex. The early increase in nNOS protein in IMCD may contribute to
enhanced local production of NO and thereby represent an adaptive
response to salt intake.
nitric oxide; messenger ribonucleic acid expression; nitrates; inducible nitric oxide synthase
| |
INTRODUCTION |
|---|
|
|
|---|
NITRIC OXIDE (NO) regulates glomerular hemodynamics and renal blood flow and induces natriuresis (11). Within the kidney, the capacity to synthesize NO has been demonstrated in both tubular epithelium and vascular endothelium. Recently, the renal medulla has been shown to produce the highest levels of NO in the kidney (26). In this regard, there are at least three isoforms of nitric oxide synthase (NOS) that could contribute to medullary NO production: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). In the medulla, abundant nNOS mRNA has been demonstrated by reverse transcription-polymerase chain reaction (RT-PCR) in inner medullary collecting ducts (IMCD), with lesser expression in the vasa recta and the inner medullary thin limb (22). Bachmann et al. (3), however, demonstrated immunoreactivity for nNOS in the macula densa and afferent arteriole but did not detect nNOS in IMCD. With regard to iNOS mRNA, studies have demonstrated its presence in IMCD and inner medullary interstitial cells (1). Histochemical analysis of renal tissue, however, has not detected basal iNOS protein expression in the IMCD (2). In contrast, eNOS mRNA and protein are distributed in endothelial cells throughout the renal vasculature, although expression of this isoform in renal tubules is not consistently detected (20, 25).
In rats, chronic infusion of an inhibitor of NOS directly into the
renal medullary interstitium results in a selective decrease in
medullary blood flow, associated with salt and water retention and
development of hypertension (14). Inhibition of nNOS expression by
intramedullary antisense oligonucleotide administration increases blood
pressure in rats maintained on a high-salt diet, suggesting that the
ability of the kidneys to excrete sodium may be impaired in the absence
of medullary nNOS activity (12). Furthermore, during high dietary salt
intake, the serum concentration and urinary excretion of the NO
decomposition products NO
2 and
NO
3 increase (18), suggesting that
enhanced NO production represents an adaptive mechanism that induces
vasodilatation and natriuresis, thereby contributing to the maintenance
of normal blood pressure.
The potential importance of nNOS-derived NO in the inner medulla led us to examine whether this isoform is expressed in tubular cells of the rat IMCD and to test the hypothesis that high dietary NaCl increases nNOS expression in this segment. Our results demonstrate that nNOS protein is readily detected in IMCD by immunofluorescence and that high dietary NaCl differentially regulates nNOS mRNA and protein expression in the IMCD and renal cortex. Whereas high dietary NaCl inhibits nNOS mRNA and protein expression in the cortex, it increases nNOS protein expression without affecting mRNA levels in the IMCD. In contrast, high dietary NaCl has no effect on iNOS mRNA expression in the IMCD.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Male Sprague-Dawley rats (200-250 g) were fed a standard (0.3% NaCl, control) or high-salt (4.0% NaCl) diet (Harlan Teklad, Madison, WI) for either 3 days or 3 wk, with unlimited access to water. The diets were equivalent in contents of all other electrolytes. For 24 h prior to death, the rats were in metabolic cages for urine collection. After death, the kidneys were immediately removed for dissection of cortices and for isolation of IMCD. Kidneys from two rats were pooled for each IMCD preparation.
IMCD preparation. Rat IMCDs were isolated using a modification of the method of Grenier and Smith (8), essentially as described (10). Briefly, renal papillary tissue was rapidly minced and suspended in Krebs buffer containing (in mM) 118 NaCl, 14 glucose, 25 NaHCO3, 4.7 KCl, 2.5 CaCl2, 1.8 MgSO4, and 1.8 KH2PO4; 0.1% collagenase A (type I; Boehringer-Mannheim, Laval, Quebec, Canada); and 0.01% deoxyribonuclease (Boehringer-Mannheim). The minced tissue was incubated for 120 min at 37°C in 5% CO2-95% air with gentle agitation. After collagenase digestion, the tubule suspension was pelleted by centrifugation at 100 g for 30 s at room temperature and washed three times with Krebs buffer. The pellet was then reconstituted in a hypotonic solution consisting of Krebs buffer and sterile water (1:2 respectively, vol/vol), gently mixed for 4 min, and centrifuged at 100 g for 30 s. This procedure has been shown to disrupt all cells, except those of the IMCD (8). The tubules were washed three times with Krebs buffer and then used immediately for either RNA or protein isolation. Cell viability was assessed by trypan blue exclusion, which demonstrated that at least 95% of IMCD cells were viable.
Reverse transcription-polymerase chain reaction (RT-PCR). Total RNA was isolated from cortex and suspensions of IMCD using a commercially available kit (RNeasy; Qiagen, Chatsworth, CA). Prior to RT-PCR, residual genomic DNA was digested by incubating RNA with amplification grade DNase I (Life Technologies, Burlington, ON, Canada) for 15 min at room temperature. DNase I was inactivated by adding ethylenediaminetetraacetic acid (final concentration, 1.6 mM) followed by incubation at 65°C for 15 min. RNA quality was determined by running samples on 1% agarose-formaldehyde gels stained with ethidium bromide, and RNA concentration and purity were determined by optical density measurement at 260 and 280 nm. RNA samples were uniformly of high quality by these standards.
Serial dilutions of total RNA (6, 30, 150, and 750 ng) were prepared in
RNase-free water and reverse transcribed in a buffer containing 5 mM
MgCl2, 1× PCR buffer (50 mM
KCl, 10 mM Tris · HCl, pH 8.3), 1 mM each of
deoxynucleoside triphosphates, 1 µCi [
-32P]dCTP (sp act,
3,000 Ci/mmol; Amersham, Mississauga, ON), 20 U RNase inhibitor, 50 U
Moloney murine leukemia virus reverse transcriptase, and 2.5 µM
random hexamers (GeneAmp RNA PCR kit; Perkin-Elmer, Norwalk, CT) in a
total volume of 20 µl. After reverse transcription, reactions were
brought up to 100 µl with 1× PCR buffer supplemented with
(final concentrations) 2 mM MgCl2,
2.5 U AmpliTaq DNA polymerase
(Perkin-Elmer), and 1 µM of either nNOS- or iNOS-specific
oligonucleotide primers. After initial denaturation at 94°C for 3 min, 33 cycles of amplification [94°C for 30 s, 68°C
(nNOS) or 60°C (iNOS) for 30 s, and 72°C for 30 s] were
performed, followed by final extension at 72°C for 10 min, in a
Perkin-Elmer GeneAmp PCR system 2400 apparatus. The PCR products were
separated on ethidium bromide-stained 2% agarose gels, the gel bands
were excised, and the incorporated radioactivity was determined by liquid scintillation counting.
To determine relative differences in NOS mRNA abundance in rats on
0.3% and 4.0% NaCl diets, we used the titration analysis method as
described (17). This is a noncompetitive, semiquantitative method that
utilizes the linear relationship between the logarithm of the initial
amount of target mRNA and the logarithm of the amount of amplification
product generated, providing that the PCR reactions have not reached
plateau phase. To ensure that all data were collected before PCR
reactions reached this plateau, we measured
32P incorporation into PCR
products as a function of cycle number for both nNOS and iNOS mRNA
amplifications. In both cases, PCR product amplification was
exponential for at least 40 cycles. Accordingly, we used 33 cycles of
amplification for all further experiments. To minimize tube-to-tube
variation in PCR efficiency, we used a master mix of reaction
components in all experiments. Under these conditions, the logarithm of
incorporated radioactivity varied linearly with the logarithm of
initial RNA amount (not shown). To control for variations in RNA
isolation and for the efficiency of the reverse transcription reaction,
-actin mRNA was amplified at the time of nNOS and iNOS mRNA
amplifications. Total RNA (150 ng) was reverse transcribed and
amplified as described above, in the presence of specific primers for
-actin (20 nM). As a control for any possible genomic DNA
contamination, a reaction lacking the reverse transcriptase enzyme was
included in all experiments.
The primer sequences for nNOS, iNOS, and
-actin products are
reported in Table 1. The primers for nNOS
and iNOS were chosen from the rat brain (5) and murine macrophage (28)
cDNA sequences, respectively. The specificity of the primers was
verified through GenBank. The
-actin primers were selected according
to the human cDNA sequence (9).
|
The identity of the nNOS PCR product was confirmed by restriction enzyme digestion with either Bgl II or Sca I, which generated the expected products (210 and 389 bp and 101 and 498 bp, respectively). To confirm the fidelity of iNOS RT-PCR, the rat IMCD iNOS PCR product was subcloned, and DNA derived from a single bacterial colony was partially sequenced (92 bp, corresponding to bp 1194-1286; Ref. 28), using the Taq Cyclist DNA sequencing kit (Stratagene, La Jolla, CA). This product demonstrated 98% nucleotide identity to the murine macrophage iNOS cDNA (28) and 100% nucleotide identity to rat vascular smooth muscle iNOS cDNA (7) in the sequenced region.
Western blotting. IMCDs from 0.3% and
4.0% NaCl-fed rats were homogenized with a cell disrupter in boiling
lysis buffer [1% sodium dodecyl sulfate (SDS), 10 mM
Tris · HCl, pH 7.4]. The lysate was then boiled
for 10 min, followed by centrifugation at 12,000 g for 2 min to remove insoluble
debris. Protein concentrations in the supernatant were determined by
the Bradford method (Bio-Rad, Montreal, PQ), using bovine serum albumin
(BSA; Sigma, St.Louis, MO) as standard. Tubule lysates (20, 40, or 60 µg) were separated on 7.5% SDS-polyacrylamide gels and transferred
onto nitrocellulose membranes (Bio-Rad). The membranes were blocked
with 10% skimmed milk in Tris-buffered saline (pH 7.6) containing
0.1% Tween 20 (TBS-T) and 0.01% sodium azide for 3 h at room
temperature. The membranes were then incubated for 18 h at 4°C with
1:1,000 dilution of mouse monoclonal antibody to nNOS or 1:400 dilution
of mouse monoclonal antibody to iNOS (Transduction Laboratories,
Lexington, KY). The mouse monoclonal antibody to nNOS was raised
against a human peptide fragment of nNOS and reacts against both human and rat nNOS at 160 kDa. By Western blot analysis, we determined that
this antibody did not cross-react with endothelial cell (eNOS) protein
lysates (Transduction Laboratories) but did detect a 130-kDa band,
clearly discernible from nNOS, from cytokine-stimulated macrophages
(iNOS), as reported by the manufacturer. In some experiments, two
separate rabbit polyclonal antibodies to iNOS were used (Transduction Laboratories; Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were then incubated with 1:2,000 dilution of either anti-mouse or
anti-rabbit secondary antibodies conjugated to horseradish peroxidase
(Amersham). Primary antibodies were diluted in TBS-T supplemented with
5% skimmed milk and 0.01% sodium azide, whereas the secondary
antibodies were diluted in TBS-T supplemented with 2% milk. Proteins
were detected by enhanced chemiluminescence (ECL, Amersham) on
Hyperfilm (Amersham), according to the manufacturer's instructions.
Prestained standards were used as molecular weight markers (Bio-Rad),
and rat pituitary and macrophage lysates (4 µg, Transduction
Laboratories) were used as positive controls for nNOS and iNOS,
respectively. To control for protein loading, all membranes were
stripped and probed with a monoclonal anti-
-actin antibody (mouse
ascites fluid, Sigma). Signals on Western blots were quantified by
densitometry and corrected for the
-actin signal, using an image
analysis software program (NIH Image 1.47).
Immunofluorescence studies. IMCD segments were microdissected from rat kidney medulla, as described (16), dried onto microscope slides for 1 h at room temperature, and then fixed in a 1:1 (vol/vol) acetone-methanol mixture for 15 min at room temperature. After fixation, the tubules were permeabilized with 0.3% Triton X-100 in phosphate-buffered saline (PBS, pH 7.4) for 30 min at room temperature. Slides were then incubated in blocking buffer consisting of PBS supplemented with 1% BSA for 30 min. A 1:200 dilution of polyclonal nNOS antibody (Santa Cruz Biotechnology) was added to the slides and incubated for 18 h at 4°C. In separate experiments, this antibody did not cross-react with protein lysates (Transduction Laboratories) from cytokine-stimulated macrophages (iNOS) or endothelial cells (eNOS) on Western blots (not shown), confirming the manufacturer's description regarding its specificity. In contrast, the antibody detected the expected nNOS protein band of 160 kDa in the pituitary and IMCD lysates. IMCDs incubated in the presence of primary antibody that had been previously neutralized with the immunizing antigen were used as negative controls (Santa Cruz Biotechnology). The slides were then washed three times for 5 min each in PBS and incubated with donkey anti-rabbit secondary antibody (1:20 dilution, Amersham) conjugated to fluorescein isothiocyanate (FITC) for 60 min at 37°C. All antibodies were diluted in PBS supplemented with 0.3% Triton X-100. After three washes with PBS, the slides were covered with an anti-fade compound (PBS containing 0.1 mM phenylaminediamine and 10% glycerol) and viewed with a Zeiss Axioplan fluorescent microscope. Photographs were taken with Kodak Tri-X black and white film.
Urinary nitrate/nitrite content. Urinary nitrate/nitrite content was determined by the nitrate reductase/Griess reaction assay as described (18). First, nitrate present in the urine samples was reduced to nitrite in the presence of nicotinamide adenine dinucleotide phosphate (150 µg/ml), flavin adenine dinucleotide (3.0 µg/ml), and 0.4 U nitrate reductase (Boehringer-Mannheim) for 30 min at room temperature. Nitrite was then measured by combining reduced urine aliquots with a 1:1 mixture (vol/vol) of 1% sulfanilamide (in 30% acetic acid) and 0.1% N-(1-naphthyl)ethylenediamine dihydrochloride (in 60% acetic acid). Absorbances were read on an ELISA reader at 550 nm. Nitrate and nitrite content was calculated using nitrate and nitrite standard curves.
Urinary sodium excretion. Urinary sodium concentration was determined by flame photometry (model IL-943; Instrumentation Laboratory, Milan, Italy), kindly performed by the laboratory of Dr. D. Z. Levine (University of Ottawa).
Statistics. Results are presented as means ± SE. Data were analyzed by the unpaired Student t-test. A value of P < 0.05 was considered significant.
| |
RESULTS |
|---|
|
|
|---|
Effect of high dietary NaCl on nNOS mRNA and protein expression in IMCD and kidney cortex. Relatively high levels of nNOS mRNA are found in the IMCD (22), yet histochemical methods have been unable to detect nNOS protein in this segment (3). As shown in Fig. 1A, using a polyclonal antibody to nNOS, cells within freshly microdissected IMCDs stained strongly for nNOS, with a cytoplasmic pattern. The specificity of the response was verified by staining IMCD with nNOS antibody, which had been previously neutralized with immunizing antigen, which resulted in complete loss of immunofluorescence (Fig. 1B). A monoclonal nNOS antibody (Transduction Laboratories) also strongly stained microdissected IMCD (not shown).
|
The effect of high dietary NaCl on the expression of nNOS mRNA and
protein in IMCD was determined, using RT-PCR and Western blotting,
respectively. In rats fed a 4.0% NaCl diet for 3 days or 3 wk, urinary
sodium excretion significantly increased (Table 2, P < 0.001 vs. 0.3% NaCl diet). This was associated with significant increases in urinary
NO
2/NO
3 excretion (Fig. 2: 3 days of 0.3% NaCl,
2.82 ± 0.31, vs. 4.0% NaCl, 3.79 ± 0.43 µmol · 100 g body
wt
1 · 24 h
1,
P < 0.05, n = 12; 3 wk of 0.3% NaCl, 1.21 ± 0.26, vs. 4.0% NaCl, 1.92 ± 0.08 µmol · 100 g body
wt
1 · 24 h
1,
P < 0.01, n = 7). Three days of 4.0%
NaCl diet had no effect on nNOS mRNA expression in IMCD (Fig.
3) [0.3% NaCl, 19.84 ± 1.57 × 103, vs. 4.0% NaCl, 20.44 ± 3.14 × 103 cpm,
P = not significant (NS),
n = 3] but significantly
increased nNOS protein expression in IMCD (Fig.
4) (0.3% NaCl, 0.51 ± 0.12, vs. 4.0%
NaCl, 0.92 ± 0.14 arbitrary units,
P < 0.05, n = 5).
|
|
|
|
After 3 wk of 4.0% NaCl intake, both nNOS mRNA (Fig. 5) (0.3% NaCl, 11.02 ± 1.05 × 103, vs. 4.0% NaCl, 13.71 ± 3.02 × 103 cpm, P = NS, n = 3) and nNOS protein (Fig. 6: 0.3% NaCl, 1.03 ± 0.16, vs. 4.0% NaCl, 1.13 ± 0.12 arbitrary units; P = NS, n = 3) in the IMCD did not differ from control values, indicating that the salt-induced nNOS protein upregulation is transient.
|
|
Previous studies have demonstrated downregulation of renal cortical nNOS mRNA by high dietary salt (4, 20). In agreement with these studies and in contrast to our results in the IMCD, kidney cortical nNOS mRNA significantly decreased after 3 days of 4.0% NaCl intake (Fig. 7) (0.3% NaCl, 30.88 ± 4.36 × 103, vs. 4.0% NaCl, 16.4 ± 4.70 × 103 cpm; P < 0.05, n = 5). This was associated with a significant decrease in kidney cortical nNOS protein expression, determined by Western blot analysis (Fig. 8) (0.3% NaCl diet, 1.88 ± 0.14, vs. 4.0% NaCl, 0.92 ± 0.20 arbitrary units; P < 0.05, n = 5).
|
|
In all experiments, to control for possible variations in RNA isolation
and reverse transcription reactions,
-actin mRNA was PCR amplified
along with the nNOS mRNA amplifications. There were no differences in
radioactivity incorporated into
-actin PCR products among samples
derived from 0.3 or 4.0% NaCl-fed rats (not shown). Similarly, there
were no differences in
-actin protein abundance among samples
derived from 0.3 or 4.0% NaCl-fed rats by Western blot analysis.
Effect of high dietary NaCl on iNOS mRNA expression in IMCD. Basal expression of iNOS mRNA has been reported in the IMCD (15). High dietary NaCl intake had no effect on IMCD iNOS mRNA expression after either 3 days (Fig. 9) (0.3% NaCl, 3.43 ± 0.14 × 103, vs. 4.0% NaCl, 3.14 ± 0.52 × 103 cpm; P = NS, n = 5) or 3 wk (Fig. 10) (0.3% NaCl, 3.90 ± 0.32 × 103, vs. 4.0% NaCl, 4.44 ± 0.74 × 103 cpm; P = NS, n = 3).
|
|
Western blots, using a mouse monoclonal antibody to iNOS (Transduction Laboratories) and with loading of up to 100 µg protein per lane, failed to detect the expected 130-kDa iNOS protein in lysates from IMCD in either 0.3 or 4.0% NaCl-fed rats. Two other polyclonal antibodies to iNOS also did not detect the iNOS protein on Western blots.
| |
DISCUSSION |
|---|
|
|
|---|
The present studies determined the effect of high dietary salt on nNOS expression in the IMCD. Our data clearly demonstrate that nNOS mRNA and protein are expressed in the IMCD. In addition, we show that high dietary salt intake differentially regulates nNOS mRNA and protein expression in the IMCD and renal cortex but has no effect on expression of iNOS mRNA in the IMCD.
Localization of nNOS. Utilizing RT-PCR, Terada et al. (22) detected the highest levels of intrarenal nNOS mRNA in the IMCD. The results of the present study, in which we readily detected nNOS mRNA in normal rat IMCD by RT-PCR, are consistent with this study and with the data of Singh et al. (20). Previous immunolocalization studies, however, have not detected nNOS protein expression in the IMCD, although an abundance of nNOS is present in the macula densa (3). In contrast, in the present studies, immunofluorescence revealed intense cytoplasmic staining for nNOS in cells of freshly microdissected IMCD, and this staining was specific for nNOS, since preincubation of the polyclonal nNOS antibody with immunizing antigen resulted in complete elimination of immunofluorescence. Furthermore, Western blot analysis of proteins extracted from IMCD revealed a single band of ~160 kDa that comigrated with nNOS from a rat pituitary lysate, used as a positive control. Taken together, therefore, our data clearly demonstrate presence of nNOS mRNA and protein in IMCD. The explanation for the lack of detection of nNOS protein in IMCD by Bachmann et al. (3) is unclear, although we speculate that differences in either tissue processing methods, antibodies, or immunodetection methods may account for the varying results.
Regulation of nNOS by dietary salt in IMCD and cortex. Inhibition of renal medullary nNOS activity increases mean arterial pressure in rats maintained on high-salt diets, suggesting that this NOS isoform may be involved in the long-term regulation of blood pressure (12). In the present study, nNOS protein expression in the IMCD significantly increased after 3 days of high dietary NaCl, but nNOS mRNA levels remained unchanged. This suggests either increased translation of nNOS mRNA into protein or enhanced protein stability due to posttranslational modification. The regulation of nNOS gene transcription and translation, however, is incompletely understood. In this regard, nNOS mRNAs with distinct 5'-untranslated regions that are encoded by separate promoters have been described in human cerebellum (27). These mRNAs likely encode identical nNOS proteins but could differ in stability, processing, or translation efficiency. Accordingly, it is possible that high dietary salt could induce a conversion to formation of nNOS mRNA transcripts with increased efficiency of translation, via as yet undefined signaling mechanisms. Alternatively, the possibility exists that the semi-quantitative RT-PCR method utilized in the present study was not sensitive enough to detect small increases in mRNA expression that could have accounted for the increased expression of nNOS at 3 days. Our results, however, are in agreement with those of Singh et al. (20), who did not detect an effect of high-salt diet for 7 days on nNOS mRNA expression in the rat IMCD by competitive RT-PCR.
In rats on high-NaCl diet for 3 wk, IMCD nNOS mRNA and protein expression did not significantly change from control values, suggesting that the increase in nNOS protein observed at 3 days is transient. Although information regarding factors regulating nNOS expression is limited (reviewed in Ref. 11), our data suggest that the molecular signals for stimulation of nNOS protein expression are either no longer present or are counteracted by other factors after 3 wk of high-salt diet. In rat total inner medullary tissue, Mattson and Higgins (13) reported that protein expression of eNOS, nNOS, and iNOS increased significantly after 3 wk of high dietary salt intake. We cannot readily provide an explanation for these differences from our present data, although it is conceivable that high dietary salt might increase nNOS expression in other inner medullary structures, such as within renal nerves, vasa recta, or inner medullary thin limbs (3, 22). It must be noted, furthermore, that the Mattson and Higgins (13) study utilized a single monoclonal antibody to detect both nNOS and iNOS by Western blot analysis, and, in contrast to our results, they did not detect nNOS in renal cortical homogenates.
Within the renal cortex, the macula densa contains the highest levels of nNOS mRNA and protein (3, 20). In rats, salt deprivation stimulates nNOS mRNA expression in the macula densa, whereas salt loading significantly decreases mRNA expression (4, 20). Our data on nNOS mRNA expression in renal cortex, performed as a positive control for our assay system, are in agreement with these observations. In addition, we have extended these findings by demonstrating that renal cortical nNOS protein expression is significantly downregulated by high dietary salt intake. The cellular signaling mechanisms mediating the inverse relationship between salt intake and macula densa nNOS expression are unknown, but a recent study revealed that blockade of systemic AT2 ANG II receptors significantly inhibited sodium depletion-induced increases in renal interstitial cGMP levels, suggesting that AT2 receptors may be linked to stimulation of renal NO production (21). In addition to the possibility that differential regulation of nNOS expression between IMCD and renal cortex is due to separate cell signaling pathways, variable expression patterns may also be secondary to transcription of mRNAs from separate promoters, as discussed above (27). Furthermore, alternative splicing of nNOS mRNA yielding a novel nNOSµ protein isoform has been reported in skeletal muscle, suggesting that tissue-specific regulation of nNOS mRNA may occur (19).
Our data demonstrate an increase in urinary excretion of NO
decomposition products after 3 days of high dietary salt intake, a time
at which IMCD nNOS protein expression is increased but at which renal
cortical nNOS is inhibited. However, urinary excretion of
NO
2/NO
3
remained significantly increased after 3 wk of high salt intake,
despite normalization of IMCD nNOS protein expression. In rats fed a
high-salt diet for 2 wk, an increase in both serum concentration and
urinary excretion of NO
2 and
NO
3 has also been reported (18). Thus
our data suggest a dissociation between IMCD nNOS protein expression
and excretion of urinary NO products. Furthermore, although absolute
levels of urinary NO
2/NO
3
were comparable in rats at 3 days and 3 wk, we observed decreased
excretion at 3 wk, when correction for body weight was made. This
suggests there may be age-dependent effects on urinary excretion of NO
products.
The urinary excretion of NO products is complex, representing the
contributions from glomerular filtration of serum
NO
2 and
NO
3, tubular handling, and de novo
intrarenal NO synthesis. Thus the effects of enhanced nNOS protein in
IMCD on intrarenal NO production cannot be estimated from our data. The
gene expression and activity of eNOS have been shown to be upregulated
by shear stress (24), suggesting that increased urinary levels of NO
decomposition products with high salt intake could also reflect
increased intrarenal activity of this isoform. In addition, the
activity of nNOS protein may be affected by levels of intracellular
calcium or endogenous inhibitors (reviewed in Ref. 11), independent of
protein expression. Whether these mechanisms are involved in the
regulation of nNOS activity in the IMCD with high salt is unknown.
Dietary NaCl and iNOS in IMCD. Our data demonstrate tonic expression of iNOS mRNA in the IMCD of normal rats, with levels not affected by high dietary salt. Abundant iNOS mRNA has previously been detected in rat IMCD by in situ hybridization (1). Restriction mapping of iNOS RT-PCR products in rat kidney revealed that the murine macrophage homologue of iNOS was the principal isoform expressed in tubular cells, including the IMCD, with lesser amounts of the rat vascular isoform of iNOS (15). The present studies were not designed to determine the relative amounts of these two mRNAs in IMCD cells. Rather, we chose PCR primers to examine total iNOS transcript levels in this segment. In this regard, it is of interest that a recent study identified four alternatively spliced iNOS mRNAs in human tissues, including kidney, with upregulation of all splice variants by cytokines (6). Accordingly, it is possible that multiple splice variants of iNOS exist in IMCD, although our data suggest that dietary salt intake does not affect total mRNA transcript levels.
In the present studies, Western blotting with three different antibodies failed to detect iNOS protein in IMCD. Recently, immunohistochemistry using antibodies to the macrophage-type iNOS in rat kidney demonstrated strong staining in outer medulla, cortical collecting ducts, and some proximal tubules, with no detection in IMCD (2). Tojo et al. (23), using a vascular smooth muscle iNOS antibody in rat kidney, did not report iNOS staining in IMCD, although there was immunolabeling in terminal afferent arteriole, distal tubule, and thick ascending limb. Our results are in agreement with these studies and suggest that iNOS mRNA is not efficiently translated into protein in IMCD under basal conditions or with high dietary salt.
In summary, the present studies demonstrate that cells of the normal rat IMCD express nNOS mRNA and protein. Protein expression of nNOS but not mRNA is upregulated by high dietary salt after 3 days. In contrast, high-salt diet decreases renal cortical mRNA and protein expression of nNOS. These data suggest that selective activation of inner medullary nNOS could be involved in the early adaptive response to high dietary salt intake.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. W. Staines and W. Ross (University of Ottawa) for assistance with the immunofluorescence studies and for the use of the ELISA reader, respectively.
| |
FOOTNOTES |
|---|
This work was supported by a grant from the Medical Research Council of Canada (MT-11560) (to K. D. Burns).
A portion of this work was presented at the annual meeting of the American Society of Nephrology, New Orleans, LA, November 1996, and has been published in abstract form (J. Am. Soc. Nephrol. 7: 1541, 1996).
Address for reprint requests: K. D. Burns, 501 Smyth Rd., Rm. N-8, Ottawa, ON, Canada K1H 8L6.
Received 2 September 1997; accepted in final form 27 February 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Ahn, K. Y.,
M. G. Mohaupt,
K. M. Madsen,
and
B. C. Kone.
In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F748-F757,
1994
2.
Aiello, S.,
M. Noris,
M. Todeschini,
S. Zappella,
C. Goglieni,
A. Benigni,
D. Corna,
C. Zoja,
D. Cavallotti,
and
G. Remuzzi.
Renal and systemic nitric oxide synthesis in rats with renal mass reduction.
Kidney Int.
52:
171-181,
1997[Medline].
3.
Bachmann, S.,
H. M. Bosse,
and
P. Mundel.
Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F885-F898,
1995
4.
Bosse, H. M.,
R. Bohm,
S. Resch,
and
S. Bachmann.
Parallel regulation of constitutive NO synthase and renin at JGA of rat kidney under various stimuli.
Am. J. Physiol.
269 (Renal Fluid Electrolyte Physiol. 38):
F793-F805,
1995
5.
Bredt, D. S,
P. M. Hwang,
C. E. Glatt,
C. Lowenstein,
R. R. Reed,
and
S. H. Snyder.
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.
Nature
351:
714-718,
1991[Medline].
6.
Eissa, N. T.,
A. J. Strauss,
C. M. Haggerty,
E. K. Choo,
S. C. Chu,
and
J. Moss.
Alternative splicing of human inducible nitric oxide synthase mRNA.
J. Biol. Chem.
271:
27184-27187,
1996
7.
Geng, Y-J.,
M. Almqvist,
and
G. K. Hansson.
cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells.
Biochim. Biophys. Acta
1218:
421-424,
1994[Medline].
8.
Grenier, F. C.,
and
W. L. Smith.
Formation of 6-keto-PGF1
by collecting tubule cells isolated from rabbit renal papillae.
Prostaglandins
16:
759-772,
1978.
9.
Gunning, P.,
P. Ponte,
H. Okayama,
J. Engel,
H. Blau,
and
L. Kedes.
Isolation and characterization of full-length cDNA clones for human alpha-beta, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.
Mol. Cell. Biol.
3:
787-795,
1983
10.
Kohan, D. E.,
A. K. Hughes,
and
S. L. Perkins.
Characterization of endothelin receptors in the inner medullary collecting duct of the rat.
J. Biol. Chem.
267:
12336-12340,
1992
11.
Kone, B. C.,
and
C. Baylis.
Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.
Am. J. Physiol.
272 (Renal Physiol. 41):
F561-F578,
1997
12.
Mattson, D. L.,
and
T. G. Bellehumeur.
Neuronal nitric oxide synthase in rat renal medulla and blood pressure regulation.
Hypertension
28:
297-303,
1996
13.
Mattson, D. L.,
and
D. J. Higgins.
Influence of dietary sodium intake on renal medullary nitric oxide synthase.
Hypertension
27:
688-692,
1996
14.
Mattson, D. L.,
S. Lu,
K. Nakanishi,
P. E. Papanek,
and
A. W. Cowley, Jr.
Effect of chronic renal medullary nitric oxide inhibition on blood pressure.
Am. J. Physiol.
266 (Heart Circ. Physiol. 35):
H1918-H1926,
1994
15.
Mohaupt, M. G.,
J. L. Elzie,
K. Y. Ahn,
W. L. Clapp,
C. S. Wilcox,
and
B. C. Kone.
Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney.
Kidney Int.
46:
653-665,
1994[Medline].
16.
Nadler, S. P.,
J. A. Zimpelmann,
and
R. L. Hebert.
PGE2 inhibits water permeability at a post-cAMP site in rat terminal inner medullary collecting duct.
Am. J. Physiol.
262 (Renal Fluid Electrolyte Physiol. 31):
F229-F235,
1992
17.
Robin, N. M.,
C. Q. Vu,
W. Tetzlaff,
and
B. J. Jasmin.
Neural regulation of acetylcholinesterase mRNAs at mammalian neuromuscular synapses.
J. Cell Biol.
127:
1061-1069,
1994
18.
Shultz, P. J.,
and
J. P. Tolins.
Adaptation to increased dietary salt intake in the rat.
J. Clin. Invest.
91:
642-650,
1993.
19.
Silvagno, F.,
H. Xia,
and
D. S. Bredt.
Neuronal nitric oxide synthase-µ, an alternatively spliced isoform expressed in differentiated skeletal muscle.
J. Biol. Chem.
271:
11204-11208,
1996
20.
Singh, I.,
M. Grams,
W-H. Wang,
T. Yang,
P. Killen,
A. Smart,
J. Schnermann,
and
J. P. Briggs.
Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F1027-F1037,
1996
21.
Siragy, H. M.,
and
R. M. Carey.
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
J. Clin. Invest.
100:
264-269,
1997[Medline].
22.
Terada, Y.,
K. Tomita,
H. Nonoguchi,
and
F. Marumo.
Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments.
J. Clin. Invest.
90:
659-665,
1992.
23.
Tojo, A.,
S. S. Gross,
L. Zhang,
C. C. Tisher,
H. H. H. W. Schmidt,
C. S. Wilcox,
and
K. M. Madsen.
Immunocytochemical localization of distinct isoforms of nitric oxide synthase in the juxtaglomerular apparatus of normal rat kidney.
J. Am. Soc. Nephrol.
4:
1438-1447,
1994[Abstract].
24.
Topper, J. N.,
J. Cai,
D. Falb,
and
M. A. Gimbrone, Jr.
Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress.
Proc. Natl. Acad. Sci. USA
93:
10417-10422,
1996
25.
Ujiie, K.,
J. Yuen,
L. Hogarth,
R. Danziger,
and
R. A. Star.
Localization and regulation of endothelial NO synthase mRNA expression in rat kidney.
Am. J. Physiol.
267 (Renal Fluid Electrolyte Physiol. 36):
F296-F302,
1994
26.
Zou, A-P.,
and
A. W. Cowley, Jr.
Nitric oxide in renal cortex and medulla.
Hypertension
29:
194-198,
1997
27.
Xie, J.,
P. Roddy,
T. K. Rife,
F. Murad,
and
A. P. Young.
Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription.
Proc. Natl. Acad. Sci. USA
92:
1242-1246,
1995
28.
Xie, Q-W.,
H. J. Cho,
J. Calaycay,
R. A. Mumford,
K. M. Swiderek,
T. D. Lee,
A. Ding,
T. Troso,
and
C. Nathan.
Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.
Science
256:
225-228,
1992
This article has been cited by other articles:
![]() |
D. Nakano, J. S. Pollock, and D. M. Pollock Renal medullary ETB receptors produce diuresis and natriuresis via NOS1 Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1205 - F1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Cheng, M.-Z. Zhang, and R. C. Harris Nitric oxide stimulates cyclooxygenase-2 in cultured cTAL cells through a p38-dependent pathway Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1391 - F1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-H. Han, J.-M. Lim, W.-Y. Kim, H. Kim, K. M. Madsen, and J. Kim Expression of endothelial nitric oxide synthase in developing rat kidney Am J Physiol Renal Physiol, April 1, 2005; 288(4): F694 - F702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1 Am J Physiol Renal Physiol, January 1, 2005; 288(1): F58 - F64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zimpelmann, N. Li, and K. D. Burns Nitric oxide inhibits superoxide-stimulated urea permeability in the rat inner medullary collecting duct Am J Physiol Renal Physiol, December 1, 2003; 285(6): F1160 - F1167. [Abstract] [Full Text] |
||||
![]() |
A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Komers and S. Anderson Paradoxes of nitric oxide in the diabetic kidney Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1121 - F1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Martin, M. Bianchi, F. Roger, L. Niksic, and E. Feraille Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla Am J Physiol Renal Physiol, September 1, 2002; 283(3): F559 - F568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Role of Angiotensin II and Free Radicals in Blood Pressure Regulation in a Rat Model of Renal Hypertension Hypertension, September 1, 2001; 38(3): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Loscalzo Salt-Sensitive Hypertension and Inducible Nitric Oxide Synthase: Form-Function Dichotomy of a Coding Region Mutation, Mutatis Mutandis Circ. Res., August 17, 2001; 89(4): 292 - 294. [Full Text] [PDF] |
||||
![]() |
R. Komers, J. N. Lindsley, T. T. Oyama, K. M. Allison, and S. Anderson Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes Am J Physiol Renal Physiol, September 1, 2000; 279(3): F573 - F583. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-F. Cheng, J.-L. Wang, M.-Z. Zhang, James. A. McKanna, and R. C. Harris Nitric oxide regulates renal cortical cyclooxygenase-2 expression Am J Physiol Renal Physiol, July 1, 2000; 279(1): F122 - F129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Solhaug, X. Q. Dong, R. D. Adelman, and K.-W. Dong Ontogeny of neuronal nitric oxide synthase, NOS I, in the developing porcine kidney Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1453 - R1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roczniak, D. Z. Levine, and K. D. Burns Localization of protein inhibitor of neuronal nitric oxide synthase in rat kidney Am J Physiol Renal Physiol, May 1, 2000; 278(5): F702 - F707. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ni, F. Oveisi, and N. D. Vaziri Nitric Oxide Synthase Isotype Expression in Salt-Sensitive and Salt-Resistant Dahl Rats Hypertension, October 1, 1999; 34(4): 552 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Braam Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1551 - R1561. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |